除了细胞毒性T细胞:重新编程的调节性T细胞有助于促进对双重检查点封锁的反应
Tullia C Bruno1,2,3, Anthony R Cillo1,2,3,4
1UPMC Hillman Cancer Center, University of Pittsburgh, PA, USA.
Molecular oncology
|June 15, 2025
概括
双重阻断PD1和LAG3通过重编程调节性T细胞 (Tregs) 来增强抗瘤免疫力. 这种组合疗法在LAG3表达高的模型中是有效的,并且在黑色素瘤患者中显示出有前途.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症免疫疗法癌症免疫疗法
背景情况:
- 组合免疫疗法越来越多地用于癌症治疗.
- 了解这些疗法的作用机制至关重要.
- 关于PD1和LAG3的双重阻断如何增强抗瘤免疫力的知识缺口存在.
研究的目的:
- 在小鼠瘤模型中研究LAG3表达在T细胞中的作用.
- 为了确定抗PD1和抗LAG3联合治疗的疗效.
- 阐明与治疗反应相关的调节性T细胞 (Tregs) 的变化.
主要方法:
- 基于LAG3表达 (LAG3hi或LAG3lo) 的小鼠瘤模型的分类.
- 对抗PD1单一疗法的反应与抗PD1+抗LAG3联合疗法的反应评估.
- 对Treg重编程的分析,包括对Foxp3和Tbet表达的分析,以应对组合疗法.
- 在转移性黑色素瘤患者中,Treg重编程与临床结果的相关性.
主要成果:
- LAG3hi模型对单独的抗PD1无反应,但对抗PD1 + 抗LAG3联合治疗有反应.
- 组合疗法诱导了CD4+ Tregs从免疫抑制剂重编程到炎症状态 (Foxp3的损失,Tbet的增加).
- 在响应抗PD1+抗LAG3治疗的转移性黑色素瘤患者中观察到类似的重编程Treg状态,与更长的生存时间相关.
结论:
- 双重阻断PD1和LAG3可以克服LAG3hi瘤对抗PD1治疗的耐药性.
- 重编程Tregs是组合免疫疗法增强抗瘤免疫力的关键机制.
- 除了细胞毒性CD8+T细胞之外的细胞,如Tregs,是免疫疗法反应的重要驱动因素.
- 这项研究为进一步的癌症免疫治疗机制和转化研究提供了基础.
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Cytotoxic T Cells-mediated Immune Response
2.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
T Cell Activation and Clonal Selection
5.9K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
5.9K
Cell-mediated Immune Responses
74.3K
Overview
74.3K


